Brief: Astrazeneca sells non-US global rights for gastroenterology drug to Tillotts Pharma

Zeria Pharmaceutical

09/07/2015 07:32

July 9 (Reuters) - Astrazeneca Plc  AZN.L  
    * Agreement with Tillotts on Entocort 
    * Entered into an agreement with Tillotts Pharma AG, part of 
Zeria Group, for divestment of global rights, outside US, to 
Entocort 
    * Tillotts will pay AstraZeneca $215 million upon completion 
of transaction to acquire rights to sell and develop Entocort 
capsules and Enema formulations outside US 
    * Transaction does not include transfer of any AstraZeneca 
employees or facilities 
    * Transaction is expected to complete in second half of 
2015, subject to customary closing conditions, and it does not 
impact AstraZeneca's financial guidance for 2015. 
 
Source text for Eikon:  ID:nRSI5879Sa  
Further company coverage:  AZN.L  
 
 ((Bengaluru Newsroon +918067491136;))